Ashwini Agarwal, Founder & Partner at Demeter Advisors, sees selective opportunities in pharma. He points to encouraging progress in novel drug discovery but warns that the domestic market is shifting more towards generics.
Ashwini Agarwal, Founder & Partner at Demeter Advisors, sees selective opportunities in pharma. He points to encouraging progress in novel drug discovery but warns that the domestic market is shifting more towards generics.